The company has a subsidiary, Angel Biomedical, which is also in administration. Share-trading in AIM-listed Angel Biotechnology Holdings has ceased. KPMG said the companies had incurred losses, most recently as a result of difficult trading conditions.
According to Stockopedia.co.uk the top holdings in the Biotech Growth Trust are on the following 2015 valuations; Biogen, 24.5x earnings for 38.7 per cent forecast growth, Celgene 23.8x for 96.8 per cent growth, Amgen 16.9x for 30 per cent growth ...
Hot biotech startups are attracting increased venture funding, and venture investors are ensuring a slot in the financing of these types of companies by starting the company themselves, Brian Gormley reports for Dow Jones VentureWire.
Had you invested �1,000 in As Seen on Screen Holdings, the name of the online fashion portal when it listed on Aim in 2001, your initial investment would now be worth a stylish �162,130, equivalent to an annualised return of 45 per cent.